Skip to content

Clinical trials

Phase 2/3 Macular Degeneration trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 2/3 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20061
20111
20131
20141
20171
20192
20201
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
EyeBiotech Ltd.2
AbbVie1
Alkeus Pharmaceuticals, Inc.1
East Florida Eye Institute1
Eyetech Pharmaceuticals1
Janssen Research & Development, LLC1
Johns Hopkins University1
Kodiak Sciences Inc1
Pacific Eye Associates1
Paul Yates, MD, PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration13
Choroidal Neovascularization6
Wet Macular Degeneration6
Geographic Atrophy3
Eye Diseases2
Retinal Degeneration2
Retinal Diseases2
Retinal Detachment1
Vision Disorders1
Vision, Low1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.